Novozymes A/S (0Q4U.IL)
| Chiusura precedente | 349,05 |
| Aperto | 348,40 |
| Denaro | 337,80 x 0 |
| Lettera | 354,70 x 0 |
| Min-Max giorno | 343,30 - 348,70 |
| Intervallo di 52 settimane | 341,70 - 499,00 |
| Volume | |
| Media Volume | 192.380 |
| Capitalizzazione | 96,339B |
| Beta (5 anni mensile) | 0,41 |
| Rapporto PE (ttm) | 26,35 |
| EPS (ttm) | 13,19 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | 6,00 (1,73%) |
| Data ex dividendo | 03 mar 2023 |
| Stima target 1A | 411,63 |
- GlobeNewswire
Novozymes delivers historically strong full-year results
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, 2026. In the 2022 financial year, Novozymes delivers 9% organic sales growth – 11% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 26.4%, and ROIC including goodwill before
- GlobeNewswire
Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large. COPENHAGEN, Denmark – December 12, 2022. The proposed combination of Novozymes A/S ("Novozymes") and Chr. Hansen Holding A/S ("Chr. Hansen") will create a strong biosolutions group wi
- GlobeNewswire
As one of the first companies in the world, Novozymes has had its net-zero target validated by the Science Based Targets initiative
Novozymes has renewed its climate targets and by 2030 will reduce its absolute CO2 emissions across its operation by 75% and reduce its absolute CO2 emissions from its supply chain by 35%. By 2050, Novozymes will reach net-zero. COPENHAGEN, Denmark – November 10, 2022. Novozymes’ first science-based targets were approved in 2019. Today Novozymes has new, SBTi approved near and long-term science-based emission reduction targets and is one of the first companies in the world to have committed to S
